Crystal Pharmatech Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Crystal Pharmatech Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11174
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Crystal Pharmatech Co Ltd (Crystal Pharmatech) is a contract research organization that conducts research on engineering and materials science for drug development. The organization offers pharmaceutical solid-state research services such as solid form screening and selection, single crystal growth and structure determination, solid-state characterization, and focused analytical solids testing. It also provides preformulation studies including early solid form screening and selection, solubility enhancement and early formulation development, physiochemical characterization, and risk assessment studies. Crystal Pharmatech offers cGMP analytical services such as method development, method validation, drug product development, stability studies, and release testing. The company has its operations in China and the US. Crystal Pharmatech is headquartered in Suzhou, China.

Crystal Pharmatech Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Laviana Pharma Raises USD15 Million in Series B Venture Financing 9
Crystal Pharmatech Raises USD10 Million in Series A Financing 10
Partnerships 11
Xceleron Enters Into Agreement With Crystal Pharmatech For Early Clinical Development 11
Crystal Pharmatech Co Ltd – Key Competitors 12
Crystal Pharmatech Co Ltd – Key Employees 13
Crystal Pharmatech Co Ltd – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Laviana Pharma Raises USD15 Million in Series B Venture Financing 9
Crystal Pharmatech Raises USD10 Million in Series A Financing 10
Xceleron Enters Into Agreement With Crystal Pharmatech For Early Clinical Development 11
Crystal Pharmatech Co Ltd, Key Competitors 12
Crystal Pharmatech Co Ltd, Key Employees 13

List of Figures
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Crystal Pharmatech Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Crystal Pharmatech Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fukuda Denshi Co Ltd (6960):医療機器:M&Aディール及び事業提携情報
    Summary Fukuda Denshi Co Ltd (Fukuda Denshi) is a medical device company, which develops, manufactures, and commercializes medical equipment including cardiology, patient monitoring, vascular screening and ultrasound systems. The company’s product portfolio includes electrocardiographs, stress tests …
  • Industrial Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Industrial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Industrial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Extendicare Inc.:企業の戦略・SWOT・財務分析
    Extendicare Inc. - Strategy, SWOT and Corporate Finance Report Summary Extendicare Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • GATX Corp (GATX):企業の財務・戦略的SWOT分析
    GATX Corp (GATX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Moorim SP Co., Ltd.:企業の戦略・SWOT・財務情報
    Moorim SP Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Moorim SP Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cermaq Group AS:企業の戦略的SWOT分析
    Cermaq Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • SmartCool Systems Inc (SSC):企業の財務・戦略的SWOT分析
    Summary SmartCool Systems Inc (SmartCool Systems) is a clean technology company that manufactures and sells energy and cost reduction technologies. The company’s products include ECO3, ESM, and soft solutions. Its ECO3 and ESM are retrofit technologies that reduce the energy consumption of compresso …
  • High Peak Royalties Limited (HPR):企業の財務・戦略的SWOT分析
    High Peak Royalties Limited (HPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Maxeda B.V.:企業の戦略・SWOT・財務情報
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Reichhold LLC 2:企業の戦略的SWOT分析
    Reichhold LLC 2 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • China Petroleum & Chemical Corp (600028):石油・ガス:M&Aディール及び事業提携情報
    Summary China Petroleum & Chemical Corp (Sinopec Corp), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and production …
  • Volt Information Sciences Inc (VOLT):企業の財務・戦略的SWOT分析
    Volt Information Sciences Inc (VOLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Enterome Bioscience SA-医療機器分野:企業M&A・提携分析
    Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome- …
  • Arkady Novikov Restaurant Group:企業の戦略・SWOT・財務分析
    Arkady Novikov Restaurant Group - Strategy, SWOT and Corporate Finance Report Summary Arkady Novikov Restaurant Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Parkson Retail Group Ltd:企業の戦略・SWOT・財務情報
    Parkson Retail Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Parkson Retail Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tuas Power Ltd:企業の戦略的SWOT分析
    Tuas Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • IBIDEN CO., LTD.:戦略・SWOT・企業財務分析
    IBIDEN CO., LTD. - Strategy, SWOT and Corporate Finance Report Summary IBIDEN CO., LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hoegh LNG Holdings Ltd (HLNG):企業の財務・戦略的SWOT分析
    Summary Hoegh LNG Holdings Ltd (Hoegh LNG), formerly known as Leif Hoegh & Co Ltd is an oil and gas company that offers floating energy solutions. The company's services include floating storage and regasification unit solutions, in-house ship management, floating LNG energy services, LNG regasifica …
  • Hellenic Telecommunications Organization SA (HTO):企業の財務・戦略的SWOT分析
    Hellenic Telecommunications Organization SA (HTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • 4P-Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary 4P-Pharma SAS (4P-Pharma) focuses on the development of novel therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆